Clinical Trial

Socializing a Science-Based Digital Therapeutic for Substance Use Disorders

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness of an intervention delivered on a smartphone. This study examines whether this intervention might improve treatment outcomes for people with substance use disorders. The intervention, called Laddr®, is a smartphone application ("app") that provides information and skills that can help people stop using substances. The social version of Laddr® being tested in this study has new features that allow people in treatment for substance use disorders to include a support person in their treatment journey, including a friend, family member, or other acquaintance. This research study will compare the effectiveness of Laddr® in combination with standard outpatient substance use treatment to standard treatment only for substance use disorders.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-12-05; most recent amendment 2025-01-02.
Status change: Recruiting → Active, Not Recruiting 2025-01-02
Trial Details
NCT Number NCT05648786
Lead Sponsor Square2 Systems, Inc.
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Substance Use Disorders, Substance-Related Disorders
Enrollment 189 participants
Start Date 2022-11-09
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-06